ELMWOOD PARK, N.J., March 26, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health enterprise (NASDAQ: OPK), today introduced the growth of its COVID-19 university tests system to guidance the return to in-human being classroom instruction throughout the region.
The Rockefeller Foundation introduced an initiative to present direction on tests for K-12 colleges and join educational institutions with laboratories and tests partners, together with BioReference.
On March 17, the Biden Administration discovered COVID-19 tests in colleges as a critical concentrate in 2021, and on Wednesday, Secretary of Training Dr. Miguel S. Cardona noted his expectation that colleges to be 100% open up for in-human being finding out in the fall. Continuing COVID-19 mitigation tactics, which includes screening, will perform an important purpose in achieving this, and helping to make certain a harmless classroom setting.
This expansion builds upon BioReference’s sturdy know-how in faculty screening like precise technologies developed for scheduling learners/staff members and reporting to mothers and fathers and colleges to rapidly recognize classes and learners that could be at danger must an person examination beneficial. Supporting two of the major college devices in the nation, BioReference delivers tests products and services for pretty much 200 colleges just about every working day and has tested just about 400,000 public university college students, principals and academics to date.
“As college systems go on to prioritize pupil protection as they do the job to reopen, screening will play an necessary job in expediting the procedure and supporting a safer in general studying knowledge for learners and their family members,” explained Jon R. Cohen, M.D., Government Chairman of BioReference Laboratories. “We’re proud to leverage our know-how in large-scale, university testing packages to expand test offerings all over the country. In assist of President Biden’s announcement to substantially maximize funding for COVID-19 university screening, BioReference is prepared to develop our prosperous product to various other university districts about the region.”
All through the COVID-19 pandemic, BioReference supported different government, municipalities and corporations with COVID-19 specimen collection and transportation, processing COVID-19 assessments, and reporting final results, acquiring executed much more than 13 million COVID-19 checks. Programs specific for school testing can incorporate RT-PCR lab-based screening as very well as swift PCR and antigen, dependent on the school and/or district wants.
For extra info on setting up a tests software for your college district, make sure you e-mail Ellen Beausang at [email protected].
About BioReference Laboratories, Inc.
BioReference Laboratories, Inc. is the biggest whole company specialty laboratory in the United States that gives health care companies and people the electric power to make assured healthcare choices. With a focus on genetics, oncology, urology and women’s overall health, BioReference features comprehensive exam solutions and unparalleled expertise based on a 40 calendar year legacy of confirmed science. The corporation is in-network with the premier well being ideas in the United States, serves about 19 million sufferers on a yearly basis, operates a community of 11 laboratory places, and is backed by a medical staff of a lot more than 300 M.D., D.O., Ph.D., genetic counselors and other experienced medical and scientific staff. With a countrywide footprint and market market knowledge, BioReference offers credible and ground breaking solutions that meet up with the requires of companies, governmental businesses, academic units, hospitals and wellbeing systems, correctional institutions, sports leagues, journey and leisure industries, and retail markets. BioReference gives field-primary custom remedies for COVID-19, together with position-of-treatment screening and huge-scale screening courses. https://www.bioreference.com/
About OPKO Wellness
OPKO is a multinational biopharmaceutical and diagnostics corporation that seeks to establish market-leading positions in big, swiftly increasing markets by leveraging its discovery, advancement, and commercialization expertise and novel and proprietary systems. For a lot more facts, visit www.opko.com.
Cautionary Assertion About Ahead-Seeking Statements
This press release consists of “forward-on the lookout statements,” as that term is defined under the Personal Securities Litigation Reform Act of 1995 (PSLRA), which statements may well be recognized by words these types of as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “intends,” “estimates,” and other phrases of identical indicating, which includes statements relating to BioReference’s experience in speedily pinpointing courses and learners that may well be at hazard, the function of screening in expediting and supporting a safer understanding ecosystem, BioReference’s potential to correctly expand its design to a number of faculty districts all around the country, as very well as other non-historic statements about our expectations, beliefs or intentions about our business, systems and products and solutions, money ailment, strategies or prospective clients. Lots of things could cause our real routines or results to differ materially from the actions and final results predicted in ahead-seeking statements. These aspects include these explained in the OPKO Health, Inc. Annual Stories on Variety 10-K filed and to be filed with the Securities and Trade Fee and in its other filings with the Securities and Trade Commission. In addition, forward-on the lookout statements may well also be adversely influenced by general market place aspects, competitive solution progress, item availability, federal and condition polices and legislation, the regulatory procedure for new goods and indications, producing troubles that might come up, patent positions and litigation, amongst other aspects. The forward-on the lookout statements contained in this push release talk only as of the day the statements ended up designed, and we do not undertake any obligation to update ahead-searching statements. We intend that all forward-searching statements be issue to the protected-harbor provisions of the PSLRA.
Hillary Titus, 201-406-9968
College Tests Inquiries
Ellen Beausang, 773-726-7492
Watch unique material to download multimedia: http://www.prnewswire.com/information-releases/bioreference-laboratories-expands-covid-19-university-testing-application-301256538.html
Supply BioReference Laboratories, Inc